Sanofi CEO calls Onduo "e-commerce". Express Scripts DHF.

Issue 031.

Get E&O weekly. | Subscribe | Digital health research from Brian Dolan.

Welcome to E&O.

Last week's newsletter had a 60 percent open rate. Here's what's happening this week:

More on this below, but the Proteus lay-offs are top of mind. There's a lot of digital health talent looking for jobs in 2020. Here's hoping they all land on their feet.
EtectRx secured FDA 510(k) clearance for its smart pill, ingestible event marker, medication adherence technology. The small company is a challenger to Proteus Digital Health, which developed a similar technology and received FDA de novo clearance back in 2012.
Happify Health published an interesting study in JMIR that showed a brief HRVB (heart rate variability biofeedback) training session on a smartphone reduced levels of salivary alpha-amylase following a stressful experience. The study used Happify's app, Breather.
Akili

Paying Subscribers Only

It's a good one, too.

This digital health research is for paying Exits & Outcomes subscribers only. Subscribe now to read this article, get the weekly newsletter, and receive unrestricted access to past and future research from the Exits & Outcomes archives. Smash the link above or below to subscribe yourself -- or head over to our pricing page to subscribe your team or your whole company!

Sanofi CEO calls Onduo “e-commerce”. Express Scripts DHF.

Welcome to E&O.

Paying Subscribers Only

Full access to E&O's research and newsletters.

Sanofi CEO calls Onduo “e-commerce”. Express Scripts DHF.

Welcome to E&O.

Paying Subscribers Only

Full access to E&O's research and newsletters.

New! E&O's free weekly newsletter.